Kleinostheim, May 23, 2005 – curasan AG (WKN 549 453), a company specialising in regenerative medicine, has today placed 250,000 new ordinary shares, in the form of bearer shares, as part of an increase in capital decided upon by the Management Board on April 20, 2005, and authorised by the Supervisory Board on April 25, 2005. The capital increase of up to EUR 250,000, from currently EUR 5,000,000 to a maximum of EUR 5,250,000, was executed within the framework of existing Authorised Capital (so-called “Genehmigtes Kapital”). The subscription right of shareholders does not apply. The issue price of the new shares is EUR 1.91 per share. The new shares shall be entitled to dividends effective from January 1, 2005.

The execution of the capital increase is expected to be entered into the Commercial Register by June 22, 2005.